Jin, Z., Wu, J., Liang, J., Yang, J., Sheng, Q., Liu, Z., . . . Dong, R. (2026). Development of a novel tyrosine kinase 2 inhibitor ARTS‐011 and its first‐in‐human single and multiple ascending dose Phase I study to evaluate the tolerability, safety, pharmacokinetic profile and food effects. Wiley. https://doi.org/10.1111/bph.70338
Style de citation Chicago (17e éd.)Jin, Zhili, et al. Development of a Novel Tyrosine Kinase 2 Inhibitor ARTS‐011 and Its First‐in‐human Single and Multiple Ascending Dose Phase I Study to Evaluate the Tolerability, Safety, Pharmacokinetic Profile and Food Effects. Wiley, 2026. https://doi.org/10.1111/bph.70338.
Style de citation MLA (9e éd.)Jin, Zhili, et al. Development of a Novel Tyrosine Kinase 2 Inhibitor ARTS‐011 and Its First‐in‐human Single and Multiple Ascending Dose Phase I Study to Evaluate the Tolerability, Safety, Pharmacokinetic Profile and Food Effects. Wiley, 2026. https://doi.org/10.1111/bph.70338.